These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 6174616)
1. Molecular relationships of the human B cell alloantigens, MT2, MB3, MT4, and DR5. Karr RW; Kannapell CC; Stein JA; Gebel HM; Mann DL; Duquesnoy RJ; Fuller TC; Rodey GE; Schwartz BD J Immunol; 1982 Apr; 128(4):1809-18. PubMed ID: 6174616 [TBL] [Abstract][Full Text] [Related]
2. Molecular identifications of HLA-DR4, MT3, and TB21 antigens on HLA-DR4 homozygous B cell lines. Maeda H; Hirata R J Immunol; 1984 Feb; 132(2):574-7. PubMed ID: 6418807 [TBL] [Abstract][Full Text] [Related]
3. Ia molecular localization of the DRw52 allodeterminant and the DRw52-like determinants defined by monoclonal antibodies. Karr RW; Lipman LK; Alber C; Koning F; Goeken NE J Immunol; 1985 Oct; 135(4):2642-6. PubMed ID: 2411807 [TBL] [Abstract][Full Text] [Related]
4. Human B cell alloantigens: expression of MB and MT determinants. Markert ML; Cresswell P J Immunol; 1982 May; 128(5):2004-8. PubMed ID: 6174619 [TBL] [Abstract][Full Text] [Related]
5. Two-dimensional gel analysis of a second family of class II molecules by polymorphic HLA-DR4,5, and w9 monoclonal antibodies. Maeda H; Hirata R; Okuyama M; Thompson A; Tohyama H J Immunol; 1984 May; 132(5):2478-84. PubMed ID: 6201545 [TBL] [Abstract][Full Text] [Related]
6. Immunochemical analysis of class II molecules expressed by a human B cell line with the unusual class II genotype, DR5+, MB1+, (MB3-), MT2+. Karr RW; Sachs JA; Festenstein H Tissue Antigens; 1985 Mar; 25(3):121-9. PubMed ID: 3890265 [TBL] [Abstract][Full Text] [Related]
7. Demonstration of structural polymorphism among MB3 light chains by two-dimensional gel electrophoresis. Ishikawa N; Kasahara M; Ikeda H; Ogasawara K; Hawkin S; Takenouchi T; Wakisaka A; Kikuchi Y; Aizawa M J Immunol; 1985 Jan; 134(1):417-22. PubMed ID: 3871113 [TBL] [Abstract][Full Text] [Related]
8. The molecules recognized by anti-MT2 alloantisera and anti-MT2-like (DRw52) monoclonal antibodies are different. Schiffenbauer J; Bono C; Schwartz BD Hum Immunol; 1985 Apr; 12(4):223-33. PubMed ID: 3872866 [TBL] [Abstract][Full Text] [Related]
9. Expression of HLA-DR, MB, MT and SB antigens on human mononuclear cells: identification of two phenotypically distinct monocyte populations. Nuñez G; Giles RC; Ball EJ; Hurley CK; Capra JD; Stastny P J Immunol; 1984 Sep; 133(3):1300-6. PubMed ID: 6611370 [TBL] [Abstract][Full Text] [Related]
10. The MT4 allodeterminant is borne on an HLA-DS molecule on DR5 cells. Zangara RJ; Kannapell CC; Karr RW; Goyert S; Silver J; Schwartz BD Scand J Immunol; 1984 Sep; 20(3):251-4. PubMed ID: 6208599 [TBL] [Abstract][Full Text] [Related]
11. Primary structural variation among serologically indistinguishable DS antigens: the MB3-bearing molecule in DR4 cells differs from the MB3-bearing molecule in DR5 cells. Giles RC; Hurley CK; Capra JD J Immunol; 1984 Jul; 133(1):1-3. PubMed ID: 6609970 [TBL] [Abstract][Full Text] [Related]
12. Serologic and immunochemical characterization of the specificity of four monoclonal antibodies to distinct antigenic determinants expressed on subpopulations of human Ia-like antigens. Quaranta V; Pellegrino MA; Ferrone S J Immunol; 1981 Feb; 126(2):548-52. PubMed ID: 6161181 [TBL] [Abstract][Full Text] [Related]
13. The distribution of DR5, MT2, and MB3 specificities on human Ia subsets. Tanigaki N; Tosi R; Sagawa K; Minowada J; Ferrara GB Immunogenetics; 1983; 17(4):371-86. PubMed ID: 6187679 [TBL] [Abstract][Full Text] [Related]
14. Separation of three class II antigens from a homozygous human B cell line. Shackelford DA; Lampson LA; Strominger JL J Immunol; 1983 Jan; 130(1):289-96. PubMed ID: 6600185 [TBL] [Abstract][Full Text] [Related]
15. Variation in HLA-DM expression influences conversion of MHC class II alpha beta:class II-associated invariant chain peptide complexes to mature peptide-bound class II alpha beta dimers in a normal B cell line. Ramachandra L; Kovats S; Eastman S; Rudensky AY J Immunol; 1996 Mar; 156(6):2196 - 2204. PubMed ID: 8690909 [TBL] [Abstract][Full Text] [Related]
16. Antigenic heterogeneity of human colorectal cancer cell lines analyzed by a panel of monoclonal antibodies. I. Heterogeneous expression of Ia-like and HLA-like antigenic determinants. MacLean GD; Seehafer J; Shaw AR; Kieran MW; Longenecker BM J Natl Cancer Inst; 1982 Aug; 69(2):357-64. PubMed ID: 6180206 [TBL] [Abstract][Full Text] [Related]
17. HLA antigens of insulin-dependent diabetics. I. PLT colonies detecting Dw10 and a new class II determinant distinct from HLA-D, DR, MB(DC), MT, and SB. Sheehy MJ; Quintieri FB; Yang SY; Alosco SM; Matsui Y; Yunis EJ; Gabbay KH Tissue Antigens; 1984 May; 23(5):290-300. PubMed ID: 6205468 [TBL] [Abstract][Full Text] [Related]
18. Polymorphism of human B-cell alloantigens: evidence for three loci within the HLA system. Markert ML; Cresswell P Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6101-4. PubMed ID: 6160591 [TBL] [Abstract][Full Text] [Related]
19. HLA-A,B antigens Ia-like antigens, and tumor-associated antigens on prostate carcinoma cell lines: serologic and immunochemical analysis with monoclonal antibodies. Ng AK; Pellegrino MA; Imai K; Ferrone S J Immunol; 1981 Aug; 127(2):443-7. PubMed ID: 6788840 [TBL] [Abstract][Full Text] [Related]
20. Evidence for polymorphism of MB3 antigens among three HLA-D clusters associated with HLA-DR4. Ikeda H; Kasahara M; Ogasawara K; Takenouchi T; Okuyama T; Ishikawa N; Wakisaka A; Kikuchi Y; Aizawa M Immunogenetics; 1984; 19(5):381-90. PubMed ID: 6202628 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]